Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program.
about
Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Initial testing (stage 1) of M ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of M ...... c Preclinical Testing Program.
@nl
type
label
Initial testing (stage 1) of M ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of M ...... c Preclinical Testing Program.
@nl
prefLabel
Initial testing (stage 1) of M ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of M ...... c Preclinical Testing Program.
@nl
P2093
P2860
P50
P356
P1476
Initial testing (stage 1) of M ...... ic Preclinical Testing Program
@en
P2093
C Patrick Reynolds
Dias Kurmashev
Jianwrong Wu
Peter J Houghton
P2860
P356
10.1002/PBC.26825
P577
2017-09-17T00:00:00Z